- This revised application focuses on the role of EGFR ligands and the related growth factors, neuregulins, and their receptors (erbB2, erbB3, erbB4) in skin biology. The premise on which the proposal is based is that crosstalk between different ligand and receptor species could amplify or diversify their signal transduction pathways and thus modulate their impact on these processes.
The specific aims are to: 1) Determine which members and forms of the EGF family of ligands and receptors are active in normal and injured skin; 2) examine ligand-dependent interactions between erbB receptors in skin and their effects on signal transduction and cellular behavior in vitro, and 3) evaluate in interference with EGFR and erbB2 signaling in skin in dominant-negative receptor transgenic mice expressing a kinase-deleted form of erbB2, compromise skin development or epidermal wound healing in transgenic mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29AR044829-06
Application #
6534438
Study Section
General Medicine A Subcommittee 2 (GMA)
Program Officer
Moshell, Alan N
Project Start
1998-09-15
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2004-08-31
Support Year
6
Fiscal Year
2002
Total Cost
$101,500
Indirect Cost
Name
University of South Florida
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Tampa
State
FL
Country
United States
Zip Code
33612